 |
Eczema BreakthroughsConversations between caregivers & the worlds cutting edge researchers. Author: Global Parents for Eczema Research (GPER)
Interviews with the leading scientists and innovators, hosted by Global Parents for Eczema Research (GPER), a non-profit led by parents of children with eczema. Like what we're doing? Consider donating to GPER at: www.parentsforeczemaresearch.com/donate Do you enjoy this podcast? Rate it on Apple Podcasts, Google Podcasts or Spotify! Learn more about GPER and subscribe to this podcast at: parentsforeczemaresearch.org Language: en Genres: Health & Fitness, Kids & Family, Medicine, Parenting Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
New nonsteroidal eczema cream approved for kids
Episode 47
Wednesday, 30 April, 2025
New treatment alert! The FDA recently approved Tapinarof, applied as a cream, for kids 2 years and up. We ask Dr. Leon Kircik from Icahn School of Medicine, NY, who led the clinical trials about the safety, efficacy and side effects of Tapinarof. And because we are parents too, we ask: How quickly does it work? Can you start/stop it as needed? How easy will it be to access? And more. If you like our podcast, please consider supporting it with a tax deductible donation. Research discussedTapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and ChildrenMaximal usage trial of tapinarof cream 1% once daily in pediatric patients down to 2 years of age with extensive atopic dermatitisTapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trialsTapinarof cream in the treatment of atopic dermatitis in children and adults a systematic review and meta-analysisEfficacy and safety of Ruxolitinib, Crisaborole, and Tapinarof for mild-to-moderate atopic dermatitis: a Bayesian network analysis of RCTs
